| Quarter | Score |
|---|---|
| 2022-Q4 | 49.8 |
| 2023-Q3 | 50.1 |
| 2023-Q4 | 65.5 |
| 2024-Q1 | 45.9 |
| 2024-Q2 | 45.1 |
| 2024-Q3 | 52.6 |
| 2024-Q4 | 73.7 |
| 2025-Q1 | 73.6 |
| 2025-Q2 | 58.0 |
| 2025-Q3 | 73.5 |
| 2025-Q4 | 73.8 |
| 2026-Q1 | 73.7 |
| 2026-Q2 | 58.3 |
Funds reducing exposure or consensus momentum fading
Trading 44.7% below funds' estimated purchase price
2 of 18 tracked funds hold SMRT. Avg conviction: 0.1%. Net adding. First tracked at $2.21 (current -44.7% vs tracked).
Oaktree Capital has 0.1% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 0.1% | Hold |
| Citadel Advisors | 0.0% | Add |